Financial Performance - Total revenue for the reporting period was ¥393,901,992.31, a decrease of 0.11% compared to the same period last year[18]. - Net profit attributable to shareholders increased by 13.26% to ¥37,104,468.51 from ¥32,758,996.36 in the previous year[18]. - Operating cash flow increased significantly by 493.44% to ¥42,270,181.27, compared to ¥7,122,909.84 in the same period last year[18]. - Basic earnings per share rose by 13.28% to ¥0.2474, while diluted earnings per share increased by 13.19% to ¥0.2472[18]. - Total assets at the end of the reporting period were ¥902,885,177.88, reflecting a 1.10% increase from the previous year[18]. - The company’s net assets attributable to shareholders increased by 3.23% to ¥779,753,599.82 compared to the end of the previous year[18]. - The company achieved operating revenue of 393.90 million yuan, a slight decrease of 0.11% compared to the same period last year[40]. - The net profit attributable to the parent company was 37.10 million yuan, an increase of 13.26% year-on-year[40]. - Research and development investment amounted to 12.74 million yuan, representing 3.23% of operating revenue[40]. - The company reported a total revenue of 1,500 million for the first half of 2019, reflecting a year-on-year increase of 20%[72]. - The total revenue for the first half of 2019 was 28,256 million RMB, with a net profit of 1,034 million RMB, representing a growth of 9.88% compared to the previous period[77]. Cash Flow and Financial Management - The net cash flow from operating activities surged by 493.44% to RMB 42.27 million, compared to RMB 7.12 million in the same period last year[47]. - The company's total cash inflow from operating activities was significantly higher than the cash outflow, leading to a positive cash flow situation for the first half of 2019[172]. - The cash flow from financing activities showed a net outflow of -¥16,589,984.40, an improvement from -¥30,518,104.98 in the previous year, indicating a reduction in cash outflow by approximately 45.5%[173]. - The company has engaged in high-risk entrusted financial management, with specific amounts and safety concerns noted[69]. - The expected annualized return for the financial products is 4.40% for 998 million yuan and 4.00% for 1,000 million yuan[71]. Research and Development - The company focuses on R&D in new materials and processes, with some core technologies at a leading domestic level[31]. - Research and development investment increased by 15.08% to RMB 12.74 million, up from RMB 11.07 million in the previous year[47]. - The company has achieved industry-leading product quality in China, with its alkyl glycosides and flame retardants obtaining EU REACH certification for overseas markets[87]. - The company plans to enhance its R&D capabilities by investing in the expansion of its technology research and development center to support continuous innovation[87]. Subsidiaries and Market Presence - The company has subsidiaries including 淮安晨化 and 南京晨化, which contribute to its operational capabilities[9]. - The company established a wholly-owned subsidiary, Nanjing Chenhua New Materials Technology Co., Ltd., with an investment of RMB 5 million, which obtained its business license on July 17, 2019[85]. - The company is focused on expanding its market presence through enhanced marketing strategies and product customization[41]. - The company plans to expand its market presence in 2020, targeting a 10% increase in market share[72]. Compliance and Governance - The financial report ensures the accuracy and completeness of the financial data presented, with the responsible parties affirming their accountability[3]. - The board of directors confirmed that all members attended the meeting to review the report, ensuring governance compliance[4]. - The company emphasizes its commitment to transparency and adherence to regulatory requirements in its disclosures[16]. - The company has not engaged in any related party transactions during the reporting period[104]. Environmental and Safety Measures - The company has established a wastewater treatment station that meets the standards for discharge into the town's sewage treatment company after pre-treatment[116]. - The company has implemented various environmental protection measures, including the installation of online monitoring for COD and pH values, and the construction of a 2,000 m² simple greenhouse to address outdoor storage issues[116]. - The company has not reported any violations of environmental protection laws and regulations during the reporting period[117]. - The company faces risks related to safety production and environmental protection, particularly concerning the handling of hazardous chemicals and waste emissions[89]. Shareholder Information - The total number of shares after the reduction of restricted stock will be 150,680,000 shares, with registered capital decreasing from 150.682 million RMB to 150.680 million RMB[130]. - The total number of common shareholders at the end of the reporting period is 11,048[132]. - The largest shareholder, Yu Zizhou, holds 25.44% of the shares, totaling 38,335,317 shares[132]. - The company has not conducted any repurchase transactions among its top ten shareholders during the reporting period[133]. Risks and Challenges - The company has not experienced any major product liability claims or related legal disputes since its establishment, but risks remain in this area[88]. - The company anticipates significant competition in the surfactant industry, particularly in the mid-end amino polyether segment, due to its high gross margin attracting new market participants[86]. - The company has completed REACH registration for several products, enabling sales in the EU market, which supports international business growth[31].

Financial Performance - The company's operating revenue for 2018 was ¥786,803,315.11, representing an increase of 11.86% compared to ¥703,400,869.93 in 2017[17]. - The net profit attributable to shareholders for 2018 was ¥86,198,035.33, a growth of 9.27% from ¥78,887,694.74 in 2017[17]. - The net cash flow from operating activities increased significantly by 92.43% to ¥69,471,230.08 in 2018, compared to ¥36,102,333.89 in 2017[17]. - The total assets at the end of 2018 reached ¥893,032,948.07, marking a 9.63% increase from ¥814,565,647.91 at the end of 2017[17]. - The company's basic earnings per share for 2018 was ¥0.5742, up 6.33% from ¥0.54 in 2017[17]. - The company reported a weighted average return on equity of 12.00% for 2018, down from 12.97% in 2017[17]. - The company achieved total operating revenue of 786.80 million yuan in 2018, representing a year-on-year growth of 11.86%[50]. - The net profit attributable to the parent company was 86.20 million yuan, an increase of 9.27% compared to the previous year[43]. - The gross profit margin for the fine chemical new materials industry was 22.29%, a decrease of 1.50% compared to the previous year[53]. Dividend Distribution - The company plans to distribute a cash dividend of 1.10 RMB per 10 shares to all shareholders, based on a total of 150,682,000 shares[4]. - The cash dividend distribution accounted for 100% of the total distributable profit of 259.404 million CNY[108]. - The company reported a cash dividend of 1.00 CNY per 10 shares for the year 2017, totaling 15 million CNY[109]. - In 2018, the cash dividend amount was 16,575,020.00, representing 19.23% of the net profit attributable to ordinary shareholders[111]. - In 2017, the cash dividend amount was 15,000,000.00, which accounted for 19.01% of the net profit attributable to ordinary shareholders[111]. - In 2016, the cash dividend amount was 10,000,000.00, corresponding to 18.01% of the net profit attributable to ordinary shareholders[111]. Research and Development - The company has a professional R&D team of 82 members, including 4 core technical personnel, enhancing its ability to meet customer demands[39]. - Research and development investment reached 24.85 million yuan, accounting for 3.16% of operating revenue, with a total of 34 patents filed during the period[43]. - The company added 4 national patents during the reporting period, bringing the total to 34 patents, including 29 invention patents[39]. - The company is currently in the trial production phase for several R&D projects, including high-efficiency alkyl glycosides for daily chemicals and curing agents for epoxy resins[64][65]. - The company plans to continue investing in high value-added products to strengthen its competitive advantage in the industry[45]. - The company plans to enhance R&D investment in polyurethane catalysts, which are crucial for the development of the polyurethane industry, thereby ensuring sustained demand and growth[98]. Market Presence and Strategy - The company has a diverse customer base across various industries, including polyurethane, textiles, and electronics, indicating strong market presence[27]. - The company's international market export revenue accounted for 11.48% of main business income in 2018, steadily rising from 10.67% in 2016 and 9.78% in 2017[33]. - The company exported products worth 89.92 million yuan in 2018, with export amounts increasing from 62.42 million yuan in 2016 and 68.40 million yuan in 2017[36]. - The company is focusing on expanding its market share and brand influence through optimized marketing channels and enhanced service tracking[88]. - The company aims to expand the production scale of surfactants, flame retardants, and polyurethane functional additives to meet the growing market demand over the next three years[96]. - The company plans to enhance its main business to improve overall market competitiveness and profitability[138]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and forecasts, as stated in the report[4]. - The company has faced risks related to quality control and product liability, which are critical as production scales up[102]. - The company acknowledges potential risks related to the decline in net profit growth rate and net asset return rate due to the public offering[137]. - The company is exposed to risks from increasing competition in the surfactants industry, particularly in high-margin segments[101]. - The company acknowledges the risks associated with market demand fluctuations and raw material price volatility, which could significantly impact profitability[141]. Corporate Governance and Compliance - The company’s financial report is guaranteed to be true, accurate, and complete by its board of directors and management[3]. - The company has established a mechanism to ensure that any share reductions comply with the initial public offering price and relevant regulations[115]. - The company has committed to maintaining transparency in shareholding changes and will report any changes to shareholders[114]. - The company has established measures to compensate investors for any losses incurred due to non-fulfillment of commitments[118]. - The company will strictly adhere to relevant laws and regulations regarding related party transactions to ensure transparency and compliance[125]. Sustainability and Social Responsibility - The company is committed to maintaining a sustainable growth strategy while enhancing shareholder value[184]. - The company actively engages in social responsibility initiatives, including support for underprivileged children and students, and was awarded the "Chinese Red Cross Compassion Medal" in 2018[199]. - The management emphasized a commitment to sustainability, aiming to reduce production waste by 15% over the next three years[151]. - The company is focusing on the development of eco-friendly products in response to increasing consumer demand for safety and environmental protection[94]. Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 25% based on new product launches and market expansion strategies[147]. - Future guidance includes maintaining a focus on sustainability, with plans to reduce carbon emissions by 15% over the next five years[146]. - The company plans to continue its research and development efforts to innovate new materials and technologies[184]. - The company is exploring potential mergers and acquisitions to strengthen its market position[185].

Financial Performance - Total revenue for Q1 2019 was CNY 204,883,868.21, representing a 12.36% increase compared to CNY 182,338,035.88 in the same period last year[7] - Net profit attributable to shareholders was CNY 14,583,323.29, up 22.39% from CNY 11,915,834.21 year-on-year[7] - Basic earnings per share increased by 25.00% to CNY 0.10 from CNY 0.08 in the previous year[7] - The total profit for the period was 15.87 million yuan, an increase of 20.07% compared to the previous year[16] - Net profit for the current period was ¥14,499,460.01, representing a 21.8% increase from ¥11,915,834.21 in the previous period[49] - Total operating revenue for the current period reached ¥204,883,868.21, an increase of 12.4% compared to ¥182,338,035.88 in the previous period[46] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 889,343,045.34, a 9.31% increase from CNY 813,595,267.27 at the end of the previous year[7] - Total assets decreased from ¥893,032,948.07 to ¥889,343,045.34, a decline of approximately 0.77%[38] - Current liabilities decreased from ¥105,436,610.24 to ¥89,772,764.06, a reduction of about 14.92%[39] - Non-current liabilities decreased from ¥24,256,262.34 to ¥17,648,951.96, a decrease of approximately 27.06%[39] - Total liabilities decreased from ¥129,692,872.58 to ¥107,421,716.02, a decline of around 17.14%[39] - Owner's equity increased from ¥763,340,075.49 to ¥781,921,329.32, an increase of approximately 2.43%[40] Cash Flow - The net cash flow from operating activities was negative at CNY -12,683,453.79, compared to CNY -2,155,870.67 in the same period last year[7] - Operating cash inflow for the current period was CNY 115,176,189.75, a decrease of 6.5% from CNY 123,477,281.50 in the previous period[55] - Cash and cash equivalents decreased from CNY 114,976,925.65 on December 31, 2018, to CNY 50,815,179.78 on March 31, 2019[37] - Cash and cash equivalents decreased from ¥88,949,656.48 to ¥46,686,198.35, a decline of about 47.5%[42] - Cash outflow from investment activities totaled CNY 86,139,959.93, down 17.3% from CNY 104,030,947.26 in the previous period[56] Research and Development - Research and development expenses increased by 43.33% to 6.56 million yuan, primarily due to increased investment in new product development[15] - The company successfully completed the research and development of several key projects, including high-efficiency alkyl glycosides and polyether amine curing agents[17] - The company plans to enhance its market competitiveness through the development of new technologies and products, aiming to break foreign technology monopolies[17] - The company plans to expand its R&D capabilities by investing in a new R&D building, covering an area of approximately 12,776 square meters[25] - Research and development expenses rose to ¥6,560,521.73, up 43.4% from ¥4,577,014.05 in the previous period[46] Shareholder Information - The company had a total of 11,567 common shareholders at the end of the reporting period[11] - The largest shareholder, Yu Zizhou, held 25.44% of the shares, totaling 38,335,317 shares[11] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[12] Market and Production - The company established a new branch in Shanghai, obtaining the business license on January 25, 2019[23] - The production base in Huai'an completed three projects, including 13,200 tons of end amino polyether and 15,000 tons of alkyl glycoside, which have entered trial production[23] - The company is in the trial production phase for its 15,000 tons alkyl glycoside project, which is part of its fundraising investment projects[23] Compliance and Risk Management - The company emphasizes strict quality control, with its products achieving industry-leading status in China and obtaining EU REACH certification for certain products[20] - The company has not faced any major product liability claims or related legal issues since its establishment, but recognizes the potential risks in the future[20] - The company is aware of the increasing environmental protection standards and the associated costs as it expands production[22] - The company is committed to addressing safety production risks associated with hazardous chemicals used in its manufacturing processes[22]

Financial Performance - Operating revenue for the reporting period was ¥206,032,268.58, reflecting a year-on-year growth of 15.51%[7] - Net profit attributable to shareholders was ¥31,124,626.13, representing a significant increase of 36.05% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥26,928,361.19, up by 32.83% year-on-year[7] - Basic earnings per share for the reporting period was ¥0.2066, an increase of 30.84% compared to the same period last year[7] - The weighted average return on equity was 4.32%, an increase of 0.78% compared to the previous year[7] - Total operating revenue for the third quarter reached CNY 206,032,268.58, an increase from CNY 178,361,355.82 in the previous period[40] - Net profit for the third quarter was CNY 31,124,626.13, representing a growth of 36.16% from CNY 22,878,178.95 in the previous year[43] - The total profit for the third quarter was CNY 34,600,403.49, an increase of 33.67% from CNY 25,927,795.04 in the previous year[43] - The company's operating revenue for the third quarter reached ¥618,592,618.71, an increase from ¥513,247,531.81 in the previous period[53] - Net profit for the third quarter was ¥63,883,622.49, compared to ¥62,019,528.44 in the same period last year, reflecting a growth of approximately 3%[50] - The total profit for the third quarter was ¥72,229,575.24, up from ¥70,248,414.25 in the previous year, indicating an increase of about 2.8%[50] Assets and Liabilities - Total assets at the end of the reporting period reached ¥877,803,735.77, an increase of 7.76% compared to the end of the previous year[7] - Total assets as of the end of the period were CNY 877,803,735.77, compared to CNY 814,565,647.91 at the beginning of the year[35] - Total liabilities increased to CNY 144,904,485.63 from CNY 130,768,220.34, reflecting a rise of 10.4%[35] - Owner's equity rose to CNY 732,899,250.14, up from CNY 683,797,427.57, marking an increase of 7.2%[35] - Cash and cash equivalents decreased by 86.72% to ¥23,867,121.73 from ¥179,728,839.12 due to investment in financial products[20] - The ending balance of cash and cash equivalents decreased to ¥23,867,121.73 from ¥179,425,181.78 at the beginning of the period[58] - The company’s cash and cash equivalents at the end of the period were significantly lower than the previous year’s balance of ¥148,751,169.70[58] Cash Flow - The company reported a net cash flow from operating activities of ¥22,004,859.60 for the year-to-date[7] - Operating cash flow increased to ¥22,004,859.60 from a negative cash flow of ¥20,998,944.40, driven by an increase in accounts payable for procurement[20] - The net cash flow from operating activities for the third quarter was ¥28,370,430.85, compared to a net outflow of ¥23,820,505.54 in the same period last year, indicating a significant improvement[60] - Total cash inflow from investment activities was ¥281,893,689.59, while cash outflow was ¥429,118,516.23, resulting in a net cash flow of -¥147,224,826.64 for the quarter[57] - The company reported a total cash inflow from financing activities of ¥4,959,850.57, with cash outflow amounting to ¥35,619,464.98, leading to a net cash flow of -¥30,659,614.41[61] - The cash flow from investment activities for the year-to-date was -¥127,393,257.69, showing a decrease from -¥235,157,996.83 in the previous year[60] Shareholder Information - The total number of shareholders at the end of the reporting period was 12,231[11] - The largest shareholder, Yu Zizhou, holds 25.44% of the shares, totaling 38,335,317 shares[11] Research and Development - R&D expenses grew by 67.66% to ¥16,861,243.57 from ¥10,056,760.19, reflecting increased investment in research and development[20] - Research and development expenses for the quarter were CNY 5,790,428.41, slightly higher than CNY 5,587,057.58 in the previous period[40] - Research and development expenses for the third quarter were CNY 5,790,428.41, slightly up from CNY 5,587,057.58 year-on-year[45] Other Financial Metrics - Non-recurring gains and losses amounted to ¥7,034,645.25, primarily from government subsidies and investment income[8] - Other current assets rose by 63.62% to ¥323,446,095.35 from ¥197,680,866.69, attributed to the investment of idle cash in financial products[20] - Fixed assets increased by 74.31% to ¥95,360,667.33 from ¥54,710,181.52, mainly due to the increase in fixed assets of the subsidiary Huai'an Chenhua[20] - The company reported other income of CNY 6,556,752.12, an increase from CNY 4,634,739.96 year-on-year[46] - The company recorded other income of ¥12,530,876.36, an increase from ¥10,461,338.98 in the previous period[53] - The company experienced an asset impairment loss of CNY 705,082.63 in the third quarter, down from CNY 1,849,998.12 in the previous year[45] - The gross profit margin improved to 21.63% in the third quarter, compared to 24.73% in the same period last year[45] - Gross profit margin for the period is approximately 11.1%, compared to the previous period's margin[40]

Financial Performance - Total operating revenue for the first half of 2018 was CNY 394,348,889.50, representing a 17.76% increase compared to CNY 334,886,175.99 in the same period last year[18]. - Net profit attributable to shareholders of the listed company decreased by 12.64% to CNY 32,758,996.36 from CNY 37,497,689.84 year-on-year[18]. - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 29,920,616.05, down 13.19% from CNY 34,466,574.14 in the previous year[18]. - Basic earnings per share decreased by 17.08% to CNY 0.2184 from CNY 0.2634 year-on-year[18]. - The company reported a net profit of 2,838,380.31 yuan from non-recurring gains and losses, after accounting for tax effects[22]. - The company reported a significant decrease in cash and cash equivalents, with a net decrease of ¥127,728,031.87, a decline of 390.12% compared to an increase of ¥44,025,536.40 last year[49]. - The company reported a total revenue of 43,000,000 RMB for the first half of 2018[82]. - The company reported a profit distribution of -15,000,000.00 CNY to shareholders, indicating a reduction in dividends[185]. Cash Flow and Assets - The net cash flow from operating activities improved significantly to CNY 7,122,909.84, compared to a negative cash flow of CNY -20,618,592.03 in the same period last year[18]. - Cash and cash equivalents decreased by 128.03 million yuan, a decline of 71.24%, as idle funds were used to purchase financial products[32]. - The company's cash and cash equivalents decreased from ¥179,728,839.12 to ¥51,697,149.91, a decline of approximately 71.2%[153]. - Total assets at the end of the reporting period were CNY 827,520,859.84, a 1.59% increase from CNY 814,565,647.91 at the end of the previous year[18]. - The total assets at the end of the period were reported at 390,675,000.00 CNY, reflecting growth in asset management[181]. - The total liabilities decreased from ¥130,768,220.34 to ¥124,107,951.82, a reduction of approximately 5.1%[155]. Research and Development - The company invested 11.07 million yuan in R&D during the reporting period, accounting for 2.81% of operating revenue, with a total of 33 patents held, including 27 invention patents[41][42]. - The company is committed to enhancing its research and development capabilities to drive innovation in new materials[182]. - The company plans to invest in the expansion of its technology research and development center to enhance product innovation capabilities[85]. Market and Product Development - The company focuses on the development of fine chemical new materials, with products used across various industries including polyurethane, textiles, and electronics[30]. - The company achieved an international market export revenue of 10.37% of its main business income in the first half of 2018[31]. - The company exported products worth 40.69 million yuan in the first half of 2018, with a focus on expanding its customer base both domestically and internationally[41][43]. - The company is planning to expand its market presence and is focusing on new product development to enhance its competitive edge[73]. Corporate Governance and Compliance - The board of directors has ensured the accuracy and completeness of the financial report, taking legal responsibility for any misrepresentation or omissions[3]. - The company has committed to timely disclosure of related party transactions[96]. - The company has established a decision-making system for related party transactions to ensure compliance with legal procedures[96]. - The company has made commitments regarding the management of shares held by related parties, ensuring compliance with regulatory requirements[91]. Environmental and Social Responsibility - The company is committed to environmental protection and has not faced any administrative penalties related to environmental issues during the reporting period[47]. - The company emphasizes strict quality control to maintain its leading position in the domestic market[85]. - The company is focused on addressing environmental protection and safety production risks associated with its operations[86]. Future Outlook - The company has set a future outlook with a projected revenue increase of 5.00% for the upcoming quarters[71]. - The overall financial performance indicates a positive outlook for the upcoming quarters, with strategic initiatives in place to support growth[182]. - The company anticipates a stable growth trajectory in the upcoming quarters based on current market trends[75].

Dividend Distribution - The company plans to distribute a cash dividend of 1.00 RMB per 10 shares to all shareholders, based on a total of 150,000,000 shares[4]. - The cash dividend represents 100% of the total profit distribution amount, with a distributable profit of 197,194,896.99 yuan[107]. - In the previous fiscal year, the company distributed a cash dividend of 1.00 yuan per 10 shares, totaling 10,000,000 yuan, which was 18.01% of the net profit attributable to shareholders[109]. - The cash dividend for 2015 was 1.11 yuan per 10 shares, totaling 8,325,000 yuan, which was 17.77% of the net profit attributable to shareholders[109]. - The company has maintained a consistent cash dividend policy over the past three years, with no stock dividends or capital increases planned for the current year[108]. - The total number of shares for the current dividend distribution is based on 150,000,000 shares[107]. - The company is in a growth phase and has significant capital expenditure plans, which necessitate a minimum cash dividend ratio of 20%[107]. - The cash dividend distribution is in compliance with the company's articles of association and shareholder resolutions[107]. - The company has ensured that minority shareholders have had ample opportunity to express their opinions and that their rights are protected[107]. Financial Performance - The company's operating revenue for 2017 was approximately ¥703.4 million, representing a 20.07% increase compared to ¥585.8 million in 2016[16]. - The net profit attributable to shareholders for 2017 was approximately ¥78.9 million, a 42.11% increase from ¥55.5 million in 2016[16]. - The net profit after deducting non-recurring gains and losses was approximately ¥73.5 million, up 29.67% from ¥56.7 million in 2016[16]. - The total assets at the end of 2017 reached approximately ¥814.6 million, a significant increase of 68.89% from ¥482.3 million at the end of 2016[16]. - The net assets attributable to shareholders increased by 75.03% to approximately ¥683.8 million from ¥390.7 million in 2016[16]. - The basic earnings per share for 2017 was ¥0.54, reflecting a 10.20% increase from ¥0.49 in 2016[16]. - The net cash flow from operating activities for 2017 was approximately ¥36.1 million, a decrease of 55.70% compared to ¥81.5 million in 2016[16]. - The company reported a quarterly operating revenue of approximately ¥190.2 million in Q4 2017, with a total annual revenue of approximately ¥703.4 million[18]. Research and Development - The company has invested significantly in R&D, resulting in advanced technology and production capabilities, positioning it as a leader in the fine chemical new materials sector[34]. - Research and development investment amounted to CNY 21.66 million, accounting for 3.08% of operating revenue[40]. - The company has 81 R&D personnel, representing 13.55% of the total workforce[62]. - The company holds a total of 31 patents, including 26 invention patents, 4 utility model patents, and 1 design patent[40]. - The company aims to expand the production scale of surfactants to meet the growing market demand over the next three years[95]. - In 2018, the company plans to develop new products beyond polyurethane and enhance the application of organic phosphorus flame retardants in green products and engineering plastics[96]. - The company will increase R&D investment in surfactants and gradually release production capacity for specialty polyethers and alkyl glycosides to ensure production flexibility[96]. Market and Product Development - The company has a diverse product range including new materials that improve surface performance, flame resistance, and flexibility, catering to various industries[26]. - The company operates a subsidiary, 淮安晨化, which is wholly owned[8]. - The company exported products worth 68.4 million in 2017, with international market export revenue accounting for 9.78% of total operating income[31]. - The company has established a strong customer resource advantage, with a stable and high-quality customer base, and has expanded its client reach internationally[33]. - The company has completed REACH registration for several products, enabling it to conduct sales in the EU market[31]. - The company’s surface active agent segment generated CNY 405.27 million in revenue, contributing 57.61% to total revenue[47]. - The flame retardant segment saw a revenue increase of 21.38% year-on-year, totaling CNY 172.25 million[50]. - The domestic market accounted for 90.28% of total revenue, with sales reaching CNY 635.00 million, a growth of 21.32%[47]. Risk Management and Compliance - The company emphasizes the importance of risk awareness regarding future plans and forecasts, as stated in the report[4]. - The company acknowledges potential risks related to safety production and environmental protection, particularly concerning the handling of hazardous chemicals[102]. - The company faces risks from intensified industry competition, particularly in the surfactants market, which may affect its market position[99]. - The company has implemented strict internal controls and risk management measures to enhance operational efficiency and ensure compliance with legal standards[154]. - The company is focused on maintaining compliance with regulatory requirements as it navigates its public offering process[118]. Corporate Governance - The company has committed to fair pricing in any unavoidable related transactions[114]. - The company will adhere to strict disclosure obligations regarding any related party transactions[114]. - The company has established a decision-making system to ensure compliance with regulations regarding related party transactions[114]. - The company has committed to not transferring or entrusting the management of its shares within twelve months from the date of listing, ensuring stability in shareholding[118]. - The company has fulfilled its shareholding commitment from February 13, 2017, to February 13, 2018, with no violations reported[118]. - The company has made a commitment to not use company assets for investments unrelated to its responsibilities, ensuring proper governance and resource allocation[119]. - The company has a long-term commitment to fulfill its obligations without any violations reported, indicating a strong governance framework[119]. Shareholder Information - The company issued 25 million new shares, increasing total shares from 75 million to 100 million after the IPO on February 13, 2017[166]. - The company approved a profit distribution plan on May 15, 2017, distributing a cash dividend of 1.00 yuan per 10 shares, totaling 10 million yuan, and a capital reserve increase of 5 shares for every 10 shares held[169]. - Following the profit distribution, the total shares increased from 100 million to 150 million[168]. - The company has a total of 112.5 million restricted shares, accounting for 75% of total shares[166]. - Domestic natural persons hold 66.84% of the shares, while domestic legal entities hold 4.08%[166]. - The company has no foreign shareholding, indicating a 0% foreign ownership[166]. - The company plans to lift restrictions on certain shares on February 13, 2020, affecting 38.34 million shares held by major shareholders[171]. - The company’s total share capital after the recent changes is 150 million shares, maintaining a 100% ownership structure[170]. Management and Personnel - The company has a diverse board of directors with extensive experience in various industries, including pharmaceuticals and investment management[192]. - The management team includes several vice presidents with backgrounds in finance, production, and quality control, ensuring a well-rounded leadership structure[196]. - The company has maintained a stable management team since June 2013, indicating continuity in leadership and strategy execution[195]. - The total remuneration paid to directors, supervisors, and senior management in 2017 amounted to 3.79 million yuan[198]. - The remuneration for the chairman and general manager, Yu Zizhou, was 424,300 yuan[199]. - The total number of directors, supervisors, and senior management during the reporting period was 19, including those who left the company[198]. - The company has not granted any stock incentives to directors and senior management during the reporting period[200].

Financial Performance - The company achieved total operating revenue of ¥182,338,035.88, representing a year-on-year increase of 20.42%[7] - The net profit attributable to shareholders was ¥11,915,834.21, a decrease of 31.85% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥11,624,060.27, down 32.59% year-on-year[7] - Basic earnings per share decreased by 38.46% to ¥0.08[7] - The company reported a net profit margin improvement, with undistributed profits rising to CNY 215,784,671.80 from CNY 200,958,294.77, an increase of 7.9%[45] - The net profit for Q1 2018 was CNY 14,826,377, a decrease of 16.5% from CNY 17,702,800 in Q1 2017[53] - The total profit for Q1 2018 was CNY 16,129,819, a decrease of 17.9% compared to CNY 19,473,749 in Q1 2017[52] Cash Flow and Liquidity - The net cash flow from operating activities improved significantly to -¥2,155,870.67, an increase of 93.81% compared to the previous year[7] - Cash and cash equivalents decreased by 42.92% to 102.59 million yuan primarily due to investments in financial products[18] - The cash flow from sales of goods and services increased by 45.20% to 117.95 million yuan, reflecting higher sales activity[20] - The ending balance of cash and cash equivalents was 102,594,797.09 CNY, down from 346,556,038.66 CNY in the previous period, representing a decrease of approximately 70.4%[57] - The total cash outflow for investing activities was 104,030,947.26 CNY, significantly higher than 11,322,966.09 CNY in the previous period, indicating increased capital expenditures[56] Assets and Liabilities - The total assets at the end of the reporting period were ¥813,595,267.27, a slight decrease of 0.12% from the end of the previous year[7] - The total liabilities decreased to CNY 116,647,940.56 from CNY 130,768,220.34, a reduction of 10.8%[41] - The company's fixed assets amounted to CNY 71,604,644.55, compared to CNY 54,710,181.52 at the beginning of the year, indicating a growth of 30.8%[40] - Current liabilities totaled CNY 94,141,704.56, a decrease of 12.9% from CNY 108,125,292.22 in the previous period[41] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,202[12] - The proportion of total sales from the top five customers decreased to 8.99% from 11.85% in the previous year[24] Operational Challenges and Risks - The company faces risks including intensified industry competition and challenges in new product development and technology replacement[10] - The company faces risks from intensified industry competition, particularly in the surfactant sector, which may impact future performance[27] - The company has not experienced any major product liability claims or related legal disputes since its establishment, but risks remain[26] Research and Development - The company is in the trial production phase for several new products, including organic silicon defoamers and high-efficiency alkyl glycosides[22] - The company plans to enhance its market competitiveness through the development of new materials and technologies, including a green functional material for curing agents[22] - The company plans to strengthen its R&D capabilities by utilizing raised funds to expand its technology research and development center[27] Government Support - The company received government subsidies amounting to ¥709,992.12 during the reporting period[8] Investment and Capital Expenditure - The company has invested ¥95.1 million in the construction of the Huai'an production base, which will produce 15,000 tons of alkyl glycosides annually[29] - The project for the annual production of 15,000 tons of alkyl glycosides is progressing steadily, with CNY 3,647.8 million invested so far, representing 61.82% of the planned investment[33] - The annual production project of 5,000 tons of amino polyether has not yet commenced, with no funds utilized[33] Financial Performance Trends - Total operating costs for Q1 2018 were CNY 173,576,238.30, up from CNY 135,799,957.26, reflecting a year-over-year increase of 28.0%[47] - The company's sales expenses increased to CNY 8,584,042, up from CNY 7,512,920, reflecting a rise of 14.3% year-over-year[52] - The management expenses for Q1 2018 were CNY 12,932,651, significantly higher than CNY 7,506,472 in the same quarter last year, indicating a 72.5% increase[52] - Financial expenses showed a significant increase of 2233.55% due to increased foreign exchange losses[19]

Financial Performance - Net profit attributable to shareholders rose by 67.64% to CNY 22,878,178.95 for the current period[7] - Operating revenue for the current period reached CNY 178,361,355.82, reflecting a growth of 35.16% year-on-year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 17.53% to CNY 20,272,199.96[7] - Basic earnings per share increased by 25.00% to CNY 0.15[7] - The company reported a net profit margin improvement, with undistributed profits increasing to CNY 188,230,734.79 from CNY 136,211,206.35, a growth of 38%[28] - The net profit for the third quarter of 2017 reached CNY 22,878,178.95, representing a 67.5% increase from CNY 13,648,733.33 in the previous year[35] - The total profit for the third quarter was CNY 25,927,795.04, an increase of 67.5% from CNY 15,445,595.74 in the previous year[34] - The total profit for Q3 2017 was CNY 70,248,414.25, which is a 26.6% increase compared to CNY 55,487,407.08 in Q3 2016[42] Assets and Liabilities - Total assets increased by 63.71% to CNY 789,587,788.28 compared to the end of the previous year[7] - Total liabilities increased to CNY 123,373,409.08 from CNY 91,640,922.65, representing a rise of 35%[27] - The equity attributable to shareholders of the parent company rose to CNY 666,214,379.20, up from CNY 390,675,100.05, marking an increase of 70%[28] - The company's total assets as of the end of Q3 2017 amounted to CNY 789,587,788.28, compared to CNY 482,316,022.70 at the beginning of the year, indicating a growth of 64%[28] Cash Flow - The company reported a net cash flow from operating activities of -CNY 20,998,944.40, a decline of 142.17%[7] - Cash flow from operating activities showed a net outflow of CNY 20,998,944.40 in Q3 2017, compared to a net inflow of CNY 49,793,663.49 in Q3 2016[49] - The net cash flow from operating activities was -23,820,505.54 CNY, a decrease compared to 55,575,216.12 CNY in the previous period[51] - The net cash flow from investing activities was -235,157,996.83 CNY, compared to -47,360,462.89 CNY in the previous period[51] - The net cash flow from financing activities was 233,640,546.51 CNY, compared to -8,329,402.56 CNY in the previous period[52] Shareholder Information - The total number of shareholders at the end of the reporting period was 17,387[11] - The largest shareholder, Yu Zizhou, holds 25.56% of the shares, totaling 38,335,317 shares[11] Government Subsidies - The company received government subsidies amounting to CNY 4,425,409.39, primarily as an IPO reward[8] - The company received government subsidies of ¥7,354,400 for its production base project, recognized as deferred income[18] Operating Costs and Revenue - Operating costs increased by 30.73% to ¥392,136,521.19, attributed to higher sales revenue[15] - The company's total operating costs for the third quarter were CNY 459,982,653.77, an increase of 29.6% from CNY 354,826,382.93 in the same period last year[40] - The company's operating revenue for Q3 2017 was CNY 513,247,531.81, an increase of 26.4% compared to CNY 405,864,832.73 in the same period last year[45] Investment Income - Investment income grew by 664.11% to ¥1,742,171.51, driven by increased returns from financial products[15] - The investment income for the third quarter was CNY 1,634,171.51, with no previous year data available for comparison[34] Other Financial Metrics - The weighted average return on equity decreased by 0.17% to 3.54% for the current period[7] - Cash and cash equivalents decreased to CNY 127,734,341.43 from CNY 154,081,067.62, a decline of 17%[29] - The company experienced a significant increase in sales revenue, with cash received from sales reaching CNY 305,128,787.19, up from CNY 221,448,894.63 in the same quarter last year[49]

Financial Performance - The company achieved total operating revenue of ¥334,886,175.99, representing a 22.27% increase compared to ¥273,898,917.59 in the same period last year[19]. - Net profit attributable to shareholders was ¥37,497,689.84, up 32.54% from ¥28,291,035.69 year-on-year[19]. - The net profit after deducting non-recurring gains and losses was ¥34,466,574.14, reflecting a 17.95% increase from ¥29,221,204.32 in the previous year[19]. - The company's total assets increased by 55.80% to ¥751,442,009.71 from ¥482,316,022.70 at the end of the previous year[19]. - The net assets attributable to shareholders rose by 64.04% to ¥640,875,420.86 from ¥390,675,100.05 at the end of the previous year[19]. - The basic and diluted earnings per share were both ¥0.26, a 4.00% increase from ¥0.25 in the previous year[19]. - The company reported a total of 15,364,739.74 in deferred income, compared to 14,636,139.06, reflecting a 5.0% increase[142]. - The total owner's equity at the end of the period was 640,875,000.00 CNY, indicating a significant increase from the previous year[160]. - The company reported a total comprehensive income of 38,376,011.54 CNY for the current period, reflecting a significant increase compared to the previous period[167]. Cash Flow and Financial Management - The company reported a negative net cash flow from operating activities of ¥20,618,592.03, a decline of 234.39% compared to a positive cash flow of ¥15,342,577.05 in the same period last year[19]. - The net cash flow from operating activities was negative at CNY -20,618,592.03, a significant decline of 234.39% compared to CNY 15,342,577.05 in the previous year[45]. - The company reported a total cash inflow from operating activities of 209,696,942.12, compared to 154,431,346.29 in the previous period, showing growth in cash receipts from operations[155]. - The total cash outflow from investing activities was 201,383,452.88, compared to 7,189,959.14 in the previous period, indicating a significant increase in investment expenditures[157]. - The total cash outflow for financing activities was 50,320,164.60, compared to 9,328,235.31 in the previous period, reflecting increased financial obligations[154]. - The company has no overdue principal or interest amounts from entrusted financial management, indicating effective cash management practices[60]. - The company reported a substantial increase in cash and cash equivalents, with a net increase of CNY 44,025,536.40, up 730.63% from CNY 5,300,284.38[45]. Investment and Capital Management - The company has committed to an investment project with a total investment amount of CNY 21,822 million, of which CNY 6,662.6 million has been utilized, representing 30.5% of the planned investment[56]. - The company plans to use up to CNY 10,900 million of temporarily idle raised funds and CNY 7,000 million of self-owned idle funds for cash management, focusing on safe and liquid bank principal-protected financial products[57]. - The company has committed to strict management of raised funds and profit distribution to mitigate the risk of reduced immediate returns[85]. - The company plans to adjust the usage limit for idle raised funds to CNY 15,000 million for purchasing principal-protected financial products, reflecting a proactive cash management approach[60]. Risk Management and Compliance - The company emphasizes the importance of risk management and has detailed its potential operational risks in the report[4]. - The company has committed to strict compliance with shareholding restrictions for its major shareholders and management personnel[73]. - The company has not reported any changes in its information disclosure practices during the reporting period[17]. - The company has not experienced any major litigation or arbitration matters during the reporting period[89]. - The company has not reported any major environmental issues during the reporting period[106]. - The company faces risks related to safety production, environmental protection, and the transportation of hazardous chemicals, which could impact normal operations[68]. Shareholder Information and Corporate Governance - The company completed its IPO on February 13, 2017, issuing 25 million new shares, increasing the total share capital from 75 million to 100 million shares[111]. - The largest shareholder, Yu Zizhou, holds 25.56% of the shares, totaling 38,335,317 shares[119]. - The company has a total of 75 million shares issued, with 37.5 million shares being restricted[116]. - The company has committed to avoiding any related party transactions that could harm shareholder interests[79]. - The company will disclose any related party transactions in accordance with regulatory requirements[79]. - The company has pledged not to transfer or delegate management of its shares to others within twelve months of its stock listing[83]. Research and Development - The company’s research and development investment was 4.47 million yuan, which is 1.33% of operating revenue[42]. - The company plans to invest in the expansion and renovation of its technology research and development center to enhance product innovation capabilities[67]. - The company aims to enhance its research and development capabilities to drive future growth[163]. Market Strategy and Operations - The company focuses on fine chemical new materials, with products used across various industries including polyurethane, textiles, and electronics[26]. - The company has established a direct sales model and emphasizes customer service and technical support to enhance market share[29]. - The company collaborates with Tmall to promote its room temperature silicone rubber products online[30]. - The company is exploring potential mergers and acquisitions to strengthen its market position[1]. - The company aims to achieve a revenue growth target of 15% for the upcoming fiscal year[1]. - The company is committed to improving operational efficiency and reducing costs by 10%[1].

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 扬州晨化新材料股份有限公司(以下简称"公司")于 2017 年 4 月 22 日在中 国证监会指定的创业板信息披露网站上披露了《2016 年年度报告》（公告编号： 2017-020）。由于工作人员失误，公告文件上传时全文出现多处乱码、文字图表 溢出页面现象。 证券代码：300610 证券简称：晨化股份 公告编号：2017-028 扬州晨化新材料股份有限公司 关于 2017 年年报的补充说明公告 二 0 一七年四月二十四日 现将相关内容的补充说明公告如下： 一、部分存在乱码、文字图表溢出页面现象的章节："第一节重要提示、目 录和释义"之"目录"全页；"第三节公司业务概要"之"三、核心竞争力分析" 全文；"第四节经营情况讨论与分析"之"二、主营业务分析：4、研发投入"全 文；"第五节重要事项"之"六、董事会关于报告期会计政策、会计估计变更或 重大会计差错更正的说明，七、与上年度财务报告相比，合并报表范围发生变化 的情况说明，八、聘任、解聘会计师事务所情况"全文；"第八节 董事、监事、 高级管理人员和员工情况"之"四、 ...